PCVX icon

Vaxcyte
PCVX

Overview Fund Activity

320 hedge funds and large institutions have $11.5B invested in Vaxcyte in 2024 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 138 increasing their positions, 88 reducing their positions, and 62 closing their positions.

Holders
320
Holders Change
-5
Holders Change %
-1.54%
% of All Funds
4.26%
Holding in Top 10
12
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-47.83%
% of All Funds
0.16%
New
62
Increased
138
Reduced
88
Closed
62
Calls
$48.1M
Puts
$25.7M
Net Calls
+$22.4M
Net Calls Change
-$6.81M

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$256M
2
Capital Research Global Investors
2
Capital Research Global Investors
California
$508M
3
KCM
3
Kynam Capital Management
New Jersey
$191M
4
State Street
4
State Street
Massachusetts
$372M
5
Norges Bank
5
Norges Bank
Norway
$90.1M

Top Sellers

1
DGM
1
Darwin Global Management
Jersey
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.07B
3
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$234M
4
FAM
4
Fred Alger Management
New York
$42.8M
5
CAM
5
Cormorant Asset Management
Massachusetts
$34.8M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.07B 13,091,648 -2,709,019 -17%
Vanguard Group
2
Vanguard Group
Pennsylvania
$979M 11,961,687 +521,204 +5%
BlackRock
3
BlackRock
New York
$909M 11,106,069 +439,632 +4%
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$866M 10,575,363 -346,533 -3%
RCM
5
RA Capital Management
Massachusetts
$711M 8,689,190 – –
Capital Research Global Investors
6
Capital Research Global Investors
California
$508M 6,210,523 +1,312,302 +27%
State Street
7
State Street
Massachusetts
$372M 4,539,406 +1,133,663 +33%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$364M 4,444,012 -69,744 -2%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$325M 3,966,956 -499,181 -11%
Goldman Sachs
10
Goldman Sachs
New York
$256M 3,129,604 +2,180,353 +230%
Franklin Resources
11
Franklin Resources
California
$235M 2,869,332 +82,997 +3%
T. Rowe Price Investment Management
12
T. Rowe Price Investment Management
Maryland
$234M 2,860,717 -1,193,111 -29%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$229M 2,802,888 +102,106 +4%
Westfield Capital Management
14
Westfield Capital Management
Massachusetts
$210M 2,566,759 +826,885 +48%
KCM
15
Kynam Capital Management
New Jersey
$191M 2,336,796 +1,297,508 +125%
AllianceBernstein
16
AllianceBernstein
Tennessee
$146M 1,779,362 +133,448 +8%
JPMorgan Chase & Co
17
JPMorgan Chase & Co
New York
$142M 1,735,663 +307,903 +22%
PA
18
Perceptive Advisors
New York
$141M 1,718,417 -309,191 -15%
CC
19
Commodore Capital
New York
$133M 1,625,000 +705,000 +77%
PBA
20
Paradigm Biocapital Advisors
New York
$116M 1,422,787 +795,055 +127%
Charles Schwab
21
Charles Schwab
California
$110M 1,341,773 +45,936 +4%
Jennison Associates
22
Jennison Associates
New York
$102M 1,246,551 +9,121 +0.7%
Deutsche Bank
23
Deutsche Bank
Germany
$99.3M 1,212,706 +64,522 +6%
MC
24
Maverick Capital
Texas
$98.4M 1,201,898 +225,649 +23%
ACA
25
Avoro Capital Advisors
New York
$96.2M 1,175,000 – –
1
2 3 4 5